These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1192733)

  • 1. First trimester abortion using intramuscular (15 S) 15 methyl prostaglandin F2alpha.
    Sharma SD; Hale RW
    Contraception; 1975 Oct; 12(4):445-52. PubMed ID: 1192733
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induced abortion with intramuscular administration of 15(S)-15methyl-prostaglandin F 2 alpha].
    Halle H; Lau HU; Hengst P
    Zentralbl Gynakol; 1977; 99(9):537-40. PubMed ID: 560770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of late first-trimester and early second-trimester gestations with intramuscular 15 (S)-15-methyl-prostaglandin F2alpha.
    Bolognese RJ; Corson SL
    J Reprod Med; 1976 Feb; 16(2):81-4. PubMed ID: 943540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The abortifacient effects of a newly developed vaginal silastic device impregnated with an 0.5% concentration of 15(S)-15-methyl-prostaglandin F2alpha methyl ester in the first trimester.
    Lauersen NH; Wilson KH
    Contraception; 1976 Jun; 13(6):697-705. PubMed ID: 1277841
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of abortion with intra-amniotic or intra-muscular 15(S)-15-methyl-prostaglandin F2alpha.
    Ylikorkala O; Järvinen PA
    Prostaglandins; 1975 Sep; 10(3):423-34. PubMed ID: 1105693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abortifacient effect of intramuscular prostaglandin F2alpha analogue in early midtrimester pregnancy.
    Friedman EA; Sachtleben MR; Green W
    Adv Plan Parent; 1976; 11(2):78-81. PubMed ID: 987946
    [No Abstract]   [Full Text] [Related]  

  • 7. Second trimester abortion with intramuscular injections of 15-methyl prostaglandin F2a.
    Ballard CA; Slaughter L
    Contraception; 1976 Nov; 14(5):541-9. PubMed ID: 975835
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of 15(S) 15-methyl-PGF 2 alpha-methyl ester vaginal suppositories for cervical dilatation and second trimester pregnancy termination.
    Krishna UR; Mhatre V; Ganguli AC; Purandare VN
    Contraception; 1976 Dec; 14(6):661-70. PubMed ID: 1017200
    [No Abstract]   [Full Text] [Related]  

  • 9. Intramuscular prostaglandin (15S)-15-methyl PGF2alpha (THAM) in midtrimester abortion.
    Henriques ES; Etkin RH; Lee JD; Swartz DP
    Prostaglandins; 1977 Jan; 13(1):183-91. PubMed ID: 841105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of prostaglandins by various routes for induction of abortion. Merits and demerits.
    Krishna U; Ganguli AC; Mandlekar AV; Purandare VN
    Prostaglandins; 1978 Apr; 15(4):685-93. PubMed ID: 674699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful first trimester abortion with 15(S) 15-methyl-prostaglandin F2alpha-methyl ester vaginal suppositories.
    Borell U; Bygdeman M; Leader A; Lundström V; Martin JN
    Contraception; 1976 Jan; 13(1):87-94. PubMed ID: 1245121
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study. World Health Organization Tast Force on the Use of Prostaglandins forthe Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):601-6. PubMed ID: 920761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular administration of 15-methyl prostaglandin F2alpha in mid-trimester termination of pregnancy.
    Bhalla K; Jenkins CR
    J Int Med Res; 1982; 10(1):32-4. PubMed ID: 6949846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15(S)15-methyl prostaglandin F2alpha for termination of very early human pregnancy. A comparative study of a single intramuscular injection and vaginal suppositories.
    Fylling P; Jerve F
    Prostaglandins; 1977 Oct; 14(4):785-90. PubMed ID: 339283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM; Choo HT; Cheng P
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular (15S)-15-methyl prostaglandin F2alpha for midtrimester and missed abortions.
    Sharma SD; Hale RW; Sato NE
    Obstet Gynecol; 1975 Oct; 46(4):468-72. PubMed ID: 1165883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midtrimester abortion with intramuscular injection of 15-methyl-prostaglandin F2alpha.
    Slaughter L; Ballard CA
    Contraception; 1975 May; 11(5):533-40. PubMed ID: 1139940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of prostaglandin F2alpha in abortion.
    Wolf JA; Rubinstein LM
    Am J Obstet Gynecol; 1977 Dec; 129(8):928-9. PubMed ID: 930986
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.